ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 113908 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 113908; 2) Community: the network communities that were significantly associated with the response to NSC 113908; 3) Molecule: the relationships between components within communities and NSC 113908; 4) MDR: the compounds that were significantly associated with the NSC 113908.

NSC Compound Enrichment Correlation
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0403978426119741 0.24845017
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0403978426119741 0.58561412
NSC 321491 Null 0.0403978426119741 -0.2869703
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0403978426119741 0.22859094
NSC 39215 Null 0.0403978426119741 0.010248057
NSC 603071 Aminocamptothecin 0.0403978426119741 0.25559195
NSC 606497 Camptothecin Derivative 0.0403978426119741 0.25551701
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0403978426119741 0.10339755
NSC 615534 Null 0.0403978426119741 -0.0066735566
NSC 629229 Null 0.0403978426119741 0.043998996
Total:56  Current:49    [First] [Prev] [Next] [Last]